Experimental treatment for pancreatic cancer could be breakthrough for patients

An experimental personalized mRNA vaccine for pancreatic cancer has shown major promise, with the first recipient at Memorial Sloan Kettering now cancer-free for six years. The treatment, highlighted by NBC News' Anne Thompson, could represent a breakthrough for patients.